BASILICO, Annacristina
 Distribuzione geografica
Continente #
NA - Nord America 736
EU - Europa 314
AS - Asia 227
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.282
Nazione #
US - Stati Uniti d'America 733
CN - Cina 94
SG - Singapore 92
IT - Italia 68
IE - Irlanda 62
SE - Svezia 54
FR - Francia 32
UA - Ucraina 30
DE - Germania 18
FI - Finlandia 17
KR - Corea 15
GB - Regno Unito 13
VN - Vietnam 11
BE - Belgio 8
ID - Indonesia 5
JP - Giappone 5
CA - Canada 3
NL - Olanda 3
ES - Italia 2
HU - Ungheria 2
PK - Pakistan 2
SN - Senegal 2
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
IN - India 1
NZ - Nuova Zelanda 1
RO - Romania 1
TR - Turchia 1
Totale 1.282
Città #
Chandler 111
Ann Arbor 87
Singapore 75
Dublin 62
Beijing 54
Santa Clara 39
Dearborn 28
Fairfield 26
Houston 22
Nyköping 20
Medford 18
Jacksonville 17
Torino 16
Princeton 15
Turin 15
Woodbridge 13
Villeurbanne 12
Dong Ket 11
Cambridge 10
Columbus 10
Seattle 10
Wilmington 10
Boston 9
Ashburn 8
Brussels 8
Toulouse 8
Rome 6
San Diego 6
Boardman 5
Hefei 5
Jakarta 5
Edinburgh 4
Guangzhou 4
Hangzhou 4
New York 4
Redwood City 4
Tokyo 4
Amsterdam 3
Buffalo 2
Madrid 2
Milan 2
Mountain View 2
Nepi 2
Rende 2
Serio 2
Silver Spring 2
Upper Marlboro 2
Verona 2
Zhengzhou 2
Zibido San Giacomo 2
Amiens 1
Anaheim 1
Andover 1
Atlanta 1
Auckland 1
Baltimore 1
Bologna 1
Budapest 1
Cagliari 1
Changsha 1
Düsseldorf 1
Fremont 1
Glen Mills 1
Harbin 1
Helsinki 1
Istanbul 1
Kunming 1
London 1
Los Angeles 1
Montreal 1
Mumbai 1
Nanchang 1
Nanjing 1
Nanning 1
Norwalk 1
Nuremberg 1
Ottawa 1
Pakistan 1
Palermo 1
Paris 1
Philadelphia 1
Ponzano 1
Port Lavaca 1
Reutlingen 1
San Mateo 1
Seoul 1
Shanghai 1
Shenyang 1
Springfield 1
Tianjin 1
Toronto 1
Troy 1
Vienna 1
Villadose 1
Voulangis 1
Wuhan 1
Wuhu 1
Xian 1
Xiangfan 1
Zagreb 1
Totale 842
Nome #
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth 137
MET/HGF co-targeting in pancreatic cancer: A tool to provide insight into the tumor/stroma crosstalk 133
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 123
"Active" cancer immunotherapy by anti-Met antibody gene transfer 120
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. 103
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met 93
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. 87
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 77
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 75
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers 69
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 67
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody 64
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor 63
Hgf/met axis induces tumor secretion of tenascin-c and promotes stromal rewiring in pancreatic cancer 58
A receptor-antibody hybrid hampering MET-driven metastatic spread 45
Totale 1.314
Categoria #
all - tutte 4.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 17 25 22 16 16 16 11 5
2020/2021139 6 6 8 6 15 9 14 7 13 11 10 34
2021/2022266 17 16 12 20 8 18 6 7 12 11 106 33
2022/2023322 23 28 10 26 24 76 20 31 48 2 27 7
2023/2024116 17 19 6 3 6 16 1 3 1 9 14 21
2024/2025178 1 27 16 41 93 0 0 0 0 0 0 0
Totale 1.314